Figure 2.
KCNQ channels and pharmacotherapeutic modulators in relation to the cellular membrane. Retigabine acts to open the KCNQ channel, whereas linopirdine and XE991 are channel inhibitors that act to inactivate the KCNQ channel function.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.